ENDONOVO THERAPEUTICS, INC. Notes Assumed
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Notes Assumed of $316.49 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-04-13.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesAssumed1 · last filed 2021-04-13
- ENDONOVO THERAPEUTICS, INC. notes assumed for the quarter ending 2020-12-31 was $0.00.
- ENDONOVO THERAPEUTICS, INC. notes assumed for the quarter ending 2020-09-30 was $0.00.
- ENDONOVO THERAPEUTICS, INC. notes assumed for the quarter ending 2018-12-31 was $0.00.
- ENDONOVO THERAPEUTICS, INC. notes assumed for the quarter ending 2018-09-30 was $0.00.
- ENDONOVO THERAPEUTICS, INC. notes assumed for fiscal 2020 was $316.49K.
- ENDONOVO THERAPEUTICS, INC. notes assumed for fiscal 2018 was $82.00K.
| Period end | Notes Assumed 3 month | Notes Assumed 6 month | Notes Assumed 9 month | Notes Assumed 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $0.00 derived: sum of 2 quarters · filed 2021-04-13 | $316.49K 10-K · filed 2021-04-13 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-19 | $316.49K 10-Q · filed 2020-11-19 | ||
| 2020-06-30 | $316.49K 10-Q · filed 2020-08-19 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-15 | $0.00 derived: sum of 2 quarters · filed 2019-04-15 | $82.00K 10-K · filed 2019-04-15 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $82.00K 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | $82.00K 10-Q · filed 2018-08-13 |